TruSight Oncology portfolio enables clinical research and in-vitro diagnostic CGP solutions ...
Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence ...
Qatar University (QU)'s College of Engineering will organise the Fourth World Congress on Engineering and Technology from Dec ...
Mohammad Gulrez, former Vice-Chancellor of AMU, emphasized the significance of employing appropriate agro-techniques in ...
(Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the ...